Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis

Published:2021-06 Issue: Volume:68 Page:102036
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Farmakis Ioannis T.^ORCID,Vazakidis Polychronis,Doundoulakis Ioannis,Arvanitaki Alexandra,Zafeiropoulos Stefanos,Boutou Afroditi^ORCID,Karvounis Haralambos,Giannakoulas George

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference34 articles.

1. Pulmonary hypertension in COPD;Chaouat;Eur. Respir. J.,2008

2. Pulmonary hypertension in chronic lung diseases;Seeger;J. Am. Coll. Cardiol.,2013

3. Quality of life is related to haemodynamics in precapillary pulmonary hypertension;Arvanitaki;Heart Lung Circ.,2020

4. Pathophysiology of pulmonary hypertension due to lung disease;Presberg;Curr. Opin. Pulm. Med.,2003

5. Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups;Chebib;Pulm. Circ.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Hypertension: A Contemporary Review;American Journal of Respiratory and Critical Care Medicine;2023-09-01

2. Non-invasive detection of severe PH in lung disease using magnetic resonance imaging;Frontiers in Cardiovascular Medicine;2023-04-17

3. PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis;Frontiers in Cardiovascular Medicine;2022-11-17

4. Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need;ERJ Open Research;2022-08-11